STAGE IIIC BREAST CANCER AJCC V7

This early-stage study is testing a new combination of two drugs, veliparib and carboplatin, for people with advanced HER2-negative breast cancer that has spread. The main goals are to find the safest and most effective dose and to understand the side effects. Researchers hope th…

This study is testing whether a shorter, 3-week radiation schedule is as effective as the standard 5-week schedule for preventing breast cancer from returning in the lymph nodes. It will also closely compare side effects, especially arm swelling (lymphedema), between the two grou…

This study is testing whether a comprehensive lifestyle program can improve outcomes for people with stage II or III breast cancer who are undergoing radiation therapy. The program includes dietary coaching, exercise, stress management, and social support. Researchers want to see…

This early-stage trial aims to find safe doses and understand side effects of several drug combinations for patients with advanced cancers that haven't responded to standard treatments. The study involves 155 participants with various advanced or metastatic cancers and some rare …

This study is testing whether taking two oral drugs, cediranib and olaparib, together can help control advanced cancers that have spread or cannot be surgically removed. It is for adults with specific types of advanced lung, breast, or pancreatic cancer who have already tried at …

This early-stage trial is testing a combination of two drugs, cyclophosphamide and veliparib, for people with advanced breast cancer that has spread. The main goal is to find the safest and most effective dose of this drug pair. Researchers will also check if certain markers in a…

This study is testing whether a newer hormone therapy drug called Z-Endoxifen works better than the standard drug tamoxifen for controlling advanced breast cancer. It involves 81 postmenopausal women whose cancer has spread, is fueled by estrogen, and has stopped responding to in…

This early-stage study is testing a new hormone therapy drug called Z-Endoxifen for women with advanced breast cancer that has returned or spread. The main goals are to find the safest and most effective dose and to understand the drug's side effects. The study is for women whose…

This study is testing whether a form of acupuncture using mild electrical pulses can help reduce long-term pain in women who have been treated for early-stage breast cancer. It involves 111 participants who are randomly assigned to receive either real electroacupuncture, a fake v…